| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/24/2007 | CN1901926A A composition comprising the extract of cucurbitaceae family plant or the purified extract isolated therefrom having anti-adipogenic and anti-obesity activity |
| 01/24/2007 | CN1901922A Compositions and uses thereof |
| 01/24/2007 | CN1901900A Obesity and metabolic syndrome treatment with tanshinone derivatives which increase metabolic activity |
| 01/24/2007 | CN1901897A Use of a fatty acid composition comprising at least one of EPA and DHA or any combinations thereof |
| 01/24/2007 | CN1901893A Use of sulfonamide compounds for the treatment of diabetes and/or obesity |
| 01/24/2007 | CN1901881A Compositions and dosage forms for enhanced absorption |
| 01/24/2007 | CN1901880A Compositions and dosage forms for enhanced absorption of gabapentin and pregabalin |
| 01/24/2007 | CN1901879A Administration of levodopa and carbidopa |
| 01/24/2007 | CN1900109A Amolops loloensis insulin release promoting peptide and use in producing medicine |
| 01/24/2007 | CN1900100A Rehmannia root oligose and its extracting method |
| 01/24/2007 | CN1900054A Substituted propion amide derivatives, their preparing method and use |
| 01/24/2007 | CN1899580A Anti-virus diluent |
| 01/24/2007 | CN1899565A Morning oral administration Tibetan medicine for treating diabetes and its preparing method |
| 01/24/2007 | CN1899536A Medicine for treating diabetes and hephrosis and its preparing method |
| 01/24/2007 | CN1899527A Fat reducing wind-fire clearing therapeutic liquid |
| 01/24/2007 | CN1899493A Fatty liver removing capsule an dits preparing method |
| 01/24/2007 | CN1899485A New method for treating diabetes with rehmannia root, Chinese yam and Chinese raspberry to supplement qi and strengthen yang |
| 01/24/2007 | CN1899480A Chinese medicine preparation for changing diabetes II insulin resistance and sugar, fat metabolic disorder |
| 01/24/2007 | CN1899472A Night oral administration Tibet medicine for treating diabetes and its preparing method |
| 01/24/2007 | CN1899453A Natural active matter-carthamin as lipase inhibitor |
| 01/24/2007 | CN1899418A Health oral administration Chinese medicine preparation for middle aged and old people |
| 01/24/2007 | CN1899383A Chinese medicine composition for treating diabetes II and complication and its preparing method |
| 01/24/2007 | CN1899380A Medicine for treating diabetes and nephrosis and its preparing method |
| 01/24/2007 | CN1899361A Zhenqi medicinal composition and its preparation |
| 01/24/2007 | CN1899352A Chinese medicine effective part composition for supplementing qi and recovering pulse |
| 01/24/2007 | CN1899344A Process for preparing blumea balsamifera total flavone extract and blumea balsamifera flavone extract |
| 01/24/2007 | CN1899342A Oral medicine for treating diabetes and its use |
| 01/24/2007 | CN1899340A Beggarticks extract and its use |
| 01/24/2007 | CN1899331A Extract of aceraceous plant and its extracting method and use |
| 01/24/2007 | CN1899329A Medicinal composition with blood fat reducing function |
| 01/24/2007 | CN1899324A Ginkgo Armillaria mellea oral preparation and its preparing method |
| 01/24/2007 | CN1899320A Method for processing lucid ganoderma spore oil preparations enriched with terpenes |
| 01/24/2007 | CN1899317A Dripping pill made from red rice and its preparing method |
| 01/24/2007 | CN1899314A Process for preparing lactic acid bacteria oral liquor |
| 01/24/2007 | CN1899311A Active ass-hide glue flavone nutrition oral liquor |
| 01/24/2007 | CN1899293A Use of lambda-carrageenan oligose in preparing blood vessel proliferation inhibitor |
| 01/24/2007 | CN1899272A Stabilized compositions of aqueous reduced coenzyme q solution |
| 01/24/2007 | CN1296384C Peptide having preptin functionality |
| 01/24/2007 | CN1296381C VEGF peptides and their use for inhibiting angiogenesis |
| 01/24/2007 | CN1296379C Technique for preparing malonyl ginsenoside, and application of medication in treating diabetes |
| 01/24/2007 | CN1296365C Imidazolinylmethyl aralkylsulfonamides |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/24/2007 | CN1296098C Oral insulin protecting agent |
| 01/24/2007 | CN1296094C Joint nutrient tablet |
| 01/24/2007 | CN1296090C Papaya activated biological preparation for treating human obesity |
| 01/24/2007 | CN1296082C Medication and health food in use for lowering blood sugar, improving function of intestinal tract and reducing platelet aggergation |
| 01/24/2007 | CN1296080C Liver-clearing blood pressure-lowering capsule and its preparation method |
| 01/24/2007 | CN1296055C Method for extracting bone calcium from animal bone powder |
| 01/24/2007 | CN1296053C Use of non-digestible polymeric foams to sequester ingested materials thereby inhibiting their absorption by body |
| 01/24/2007 | CN1296052C Non-injection preparation containing medium and/or low molecular weight chondroitin sulfate |
| 01/24/2007 | CN1296050C Acarbose enteric coated tablets and its preparation method |
| 01/24/2007 | CN1296039C Fatty acid analogues for the treatment of inflammatory and autoimmune disorders |
| 01/23/2007 | USRE39480 Chromium/biotin treatment of type II diabetes |
| 01/23/2007 | US7166726 Aryl substituted 3,4-dihydroanthracene derivatives having retinoid antagonist or retinoid inverse agonist type biological activity |
| 01/23/2007 | US7166707 Identifying peptide mimetic for treatment and prevention of tumors and autoimune diseases |
| 01/23/2007 | US7166639 Blocking activation of transcription factor; aminothiophene compound; tissue repair; antiarthritic agents; inflammatory bowel disorders; antihistamines;; osteoporosis; skin disorders; autoimmune diseases |
| 01/23/2007 | US7166638 Statin derivatives |
| 01/23/2007 | US7166636 Indole-amid derivatives which possess glycogen phosphorylase inhibitory activity |
| 01/23/2007 | US7166632 such as (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine; serotonin receptor antagonists (5HT/5HT2C); for treatment of obesity |
| 01/23/2007 | US7166629 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 01/23/2007 | US7166625 Method for treating fibrotic diseases and other indications |
| 01/23/2007 | US7166623 Pain and inflammation |
| 01/23/2007 | US7166622 Administering substituted phenylsulfonamide for therapy and prophylaxis of Alzheimer's Disease and Down's syndrome |
| 01/23/2007 | US7166614 CCR-2 modulators; INFLAMMATORY, IMMUNOREGULATORY, ALLERGIC, AND AUTOIMMUNE DISORDERS AND DISEASES |
| 01/23/2007 | US7166613 Condensed indoline derivatives and their use as 5HT, in particular 5HT2c, receptor ligands |
| 01/23/2007 | US7166611 Plant extract comprising steroidal glycosides from the genus Trichocaulon or Hoodia produced by solvent extraction |
| 01/23/2007 | US7166608 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 01/23/2007 | US7166605 Prophylaxis; endothelial diseases, oxidative stress, cardiovascular, inflammatory, cardiovascular, ocular, autoimmune diseases, neurological disorders and cancer, hypercholesterolemia and hyperlipidemia |
| 01/23/2007 | US7166601 A phenylamide derivatives for treating gastrointestinal reflux disorders, eating disorder obesity and irritable bowel disorder |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166597 Antiinflammatory agents; autoimmune disease treatments; pyrazolo(1,5-a)pyridine derivatives |
| 01/23/2007 | US7166596 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/23/2007 | US7166589 Quinoline derivatives |
| 01/23/2007 | US7166588 Derivatives and analogs of galanthamine |
| 01/23/2007 | US7166586 Sulfonamide lactam inhibitors of FXa and method |
| 01/23/2007 | US7166579 inhibitors of dipeptidyl peptidase; treatment of impaired glucose tolerance, glucosuria, hyperlipidaemia, metabolic acidoses, diabetes mellitus, diabetic neuropathy and nephropathy and of sequelae of diabetes mellitus in mammals |
| 01/23/2007 | US7166467 Nucleic acids, polypeptides, compositions, and methods for modulating apoptosis |
| 01/23/2007 | US7166299 Comprises ursodeoxycholic acid for treating gastritis and peptic ulcer disease |
| 01/23/2007 | US7166293 Anticancer agents; antitumor agents; cardiovascular diosrders; antiinflammatory agents |
| 01/23/2007 | CA2191747C (a)-annelated pyrrole derivatives and pharmaceutical use thereof |
| 01/18/2007 | WO2007008548A2 Methods and related compositions for treating or preventing obesity, insulin resistance disorders, and mitochondrial-associated disorders |
| 01/18/2007 | WO2007008156A1 A pharmaceutical composition comprising a substituted phenylpropionic acid as a free acid and as tert-butyl amine salt thereof |
| 01/18/2007 | WO2007007971A1 Pharmaceutical compositions comprising sibutramine |
| 01/18/2007 | WO2007007910A1 Heterocycle-substituted benzimidazole derivative |
| 01/18/2007 | WO2007007890A1 N-dihydroxyalkyl-substituted 2-oxoimidazole derivative |
| 01/18/2007 | WO2007007886A1 An oxime derivative and preparations thereof |
| 01/18/2007 | WO2007007757A1 Pharmaceutical composition containing pparϝ agonist |
| 01/18/2007 | WO2007007732A1 Agent for elevating adiponectin concentration |
| 01/18/2007 | WO2007007688A1 3,5-diamino-1,2,4-triazole derivative |
| 01/18/2007 | WO2007007656A1 Pharmaceutical composition containing thiazolidinedione compound |
| 01/18/2007 | WO2007007628A1 Choline salt crystal of azulene compound |
| 01/18/2007 | WO2007007588A1 Compound having cyclic group with planarity as core |
| 01/18/2007 | WO2007007042A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007007041A1 Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 01/18/2007 | WO2007007040A1 2 -heterocyclyloxybenzoyl amino heterocyclyl compounds as modulators of glucokinase for the treatment of type 2 diabetes |
| 01/18/2007 | WO2007006928A1 N-[(4,5-diphenylpyrimidin-2-yl)methyl]amine derivatives, the preparation thereof and their therapeutic use |
| 01/18/2007 | WO2007006760A1 Dicycloalkyl urea glucokinase activators |
| 01/18/2007 | WO2007006751A2 Use of bpi protein for the treatment of disorders of the metabolism and cardiovascular disorders |